Alerts will be sent to your verified email
Verify EmailOMKARPH
|
Omkar Pharmachem
|
Adeshwar Meditex
|
Colinz Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.2 % | 5.67 % | 4.71 % |
|
5yr average Equity Multiplier
|
1.05 | 2.23 | 1.29 |
|
5yr Average Asset Turnover Ratio
|
0.05 | 1.12 | 0.64 |
|
5yr Avg Net Profit Margin
|
44.95 % | 2.25 % | 5.84 % |
|
Price to Book
|
0.52 | 0.0 | 1.89 |
|
P/E
|
157.52 | 14.82 | 37.1 |
|
5yr Avg Cash Conversion Cycle
|
49.27 Days | 157.84 Days | -11.59 Days |
|
Inventory Days
|
0.0 | 119.5 Days | 56.66 Days |
|
Days Receivable
|
49.27 Days | 131.36 Days | 42.5 Days |
|
Days Payable
|
0.0 | 99.91 Days | 89.1 Days |
|
5yr Average Interest Coverage Ratio
|
7.4 | 2.29 | 11.55 |
|
5yr Avg ROCE
|
2.6 % | 12.9 % | 6.71 % |
|
5yr Avg Operating Profit Margin
|
44.39 % | 6.1 % | 7.54 % |
|
5 yr average Debt to Equity
|
0.06 | 0.59 | 0.07 |
|
5yr CAGR Net Profit
|
-1.89 % | 4.26 % | 18.95 % |
|
5yr Average Return on Assets
|
2.09 % | 2.58 % | 3.68 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.03 % | 57.68 % | 66.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.77 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Omkar Pharmachem
|
Adeshwar Meditex
|
Colinz Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|